NCT06249828Recruiting
Clinical Trial to Evaluate the Efficacy and Safety of MegaCarti^® in Knee Cartilage Defects
A Clinical Trial to Evaluate the Efficacy and Safety of Cartilage Regeneration in the Use of MegaCarti^® in Patients With Knee Joint Cartilage Injury: Multicenter, Independent Evaluator-subject Blinded, Microfracture-comparative, Randomized Clinical Study
L&C BioClinicalTrials.govdeviceDevice trial
Study focus
- Disease/Condition
- Osteoarthritis, Knee
- Drug/Device/Intervention
- MegaCarti^®
- Study type
- Interventional
- Intervention type
- device
Sponsor & location
- Primary sponsor
- L&C Bio
- Location
- Gyeonggi-do,Gyeonggi-do,Seoul,Seoul, South Korea
Timeline & enrollment
- Phase
- N/A
- Start date
- Jan 22, 2024
- End date
- Apr 30, 2025
- Enrollment
- 60 participants
Primary outcome
MOCART score
Summary
Subjects aged 50 to 65 years with knee cartilage defects will undergo microfracture treatment
 for cartilage regeneration and MegaCarti^® will be applied.
ICD-10 classifications
Chronic instability of kneeInjuries to the knee and lower legGonarthrosis [arthrosis of knee]Dislocation, sprain and strain of joints and ligaments of kneeSprain and strain of other and unspecified parts of knee
Data source
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06249828
- Type
- Device Trial
About this record
Access comprehensive clinical trial information for NCT06249828 through Pure Global AI's free database. This phase not specified trial is sponsored by L&C Bio and is currently Recruiting. The study focuses on Osteoarthritis, Knee. Target enrollment is 60 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.